Table 4.
Association of genotypes, pvl, muPA, and qacA/B genes
| STs | % (No./total) | MRSA/MSSA |
|---|---|---|
|
qacA/B(+) | ||
| ST239 |
18.8% (38/202) |
100.0% (38/38) |
| ST5 |
15.2% (28/184) |
96.4% (27/28) |
| ST6 |
6.3% (1/16) |
0/1 |
| ST7 |
3.7% (1/27) |
0/1 |
| ST20a |
1/5 |
0/1 |
| ST22 |
1/2 |
0/1 |
| ST1821 |
1/4 |
0/1 |
| ST359 |
1/1 |
0/1 |
|
pvl(+) | ||
| ST398 |
26.7% (4/15) |
0/4 |
| ST88 |
20.0% (2/10) |
0/2 |
| ST59 |
5.9% (1/17) |
1/0 |
| ST7 |
3.7% (1/27) |
1/0 |
| ST338 |
1/1 |
0/1 |
| ST22 |
1/2 |
0/1 |
|
muPA(+) | ||
| ST1 |
65.6% (21/32) |
100% (21/21) |
| ST630 |
16.7% (2/12) |
0/2 |
| ST398 |
13.3% (2/15) |
0/2 |
| ST59 |
11.8% (2/17) |
2/0 |
| ST5 |
10.9% (20/184) |
100.0% (20/20) |
| ST7 |
7.4% (2/27) |
0/2 |
| ST680 |
5.6% (1/18) |
1/0 |
| ST188 |
4.8% (1/21) |
0/1 |
| ST239 |
3.5% (7/202) |
7/0 |
| ST1036 |
1/2 |
0/1 |
| ST121 | 1/1 | 0/1 |
a STs with less than 10 isolates were not calculated in the percentage of genes present or MRSA/MSSA.